Choline Fenofibrate

非诺贝特胆碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCholine Fenofibrate
Drug Alias Namecholini fenofibratum胆碱非诺贝特fenofibrato de colinaTrilipixSLV348/ABT335 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsDiabetic macular oedemaSolid tumoursBurns +[21] 
Global Approved IndicationsHypercholesterolemiaDyslipidemias
Approved Indications in ChinaDyslipidemias
Original Approved Country/TerritoryUnited States
Original Approved Date2008/12/15
Country/TerritoryCzechiaBulgariaCanada +[15] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbott Medical Devices Trading (Shanghai) Co LtdUniversity Of Minnesota
Inactive CompaniesAbbott LaboratoriesDana-Farber Cancer InstituteAbbott Products +[13] 
Active IndicationsDyslipidemiasFetal Alcohol Spectrum Disorders
Inactive IndicationsDiabetic macular oedemaSolid tumoursBurns +[19] 

Other Information

ATC CodeC10AB11
Related LinksKEGG